AI in Cancer Diagnosis Market 2030|Digital Innovation Helping to Put Healthcare to the Next Level - Ibex Medical Analytics Ltd., Qlarity Imaging, Paige AI, Neurologica (Samsung)

Market Insights

Companies like Ibex Medical Analytics Ltd, Qlarity Imaging, Paige AI, and Sectra AB, among others sell AI-based software to providers such as hospitals, clinics, and laboratories which can be implemented in various imaging devices to analyze early detection of cancer, nodule detection, tumor monitoring, and such other applications.

AI in Cancer Diagnosis Market's Major Drivers

• Early diagnosis of cancer and significant treatment cost reduction
• Adoption of AI in hospitals and other healthcare institutes will drive Artificial Intelligence (AI) in the cancer diagnostics Market
• Increased awareness of cancer care advances
• Acceptance and implementation of AI enable cancer care by reputed institutes globally
• Government initiatives to encourage healthcare providers and other healthcare organizations to adopt AI-based diagnostic technologies

Get a Sample Report (including Charts, Infographics, and Figures) @ https://nforming.com/publications/ai-in-cancer-diagnosis-market/#tab-form

Rising Global Cancer Burden Coupled with Al Acceptance Boosting AI in the Cancer Diagnostics Market

The frequency of cancer-promoting habits and activities such as smoking, low food quality, and less physical inactivity has increased across the globe in economically developing nations which is also likely to continue growing in the future. According to the report of the national library of medicine (NLM), by 2030, there will be approximately 26 million new cancer cases and about 17 million cancer deaths per year.

Researchers have been working on artificial intelligence (AI) techniques that increase the level of detail in cancer imaging. AI has also demonstrated the ability to enhance cancer detection in patients who are already experiencing symptoms.

For instance, as per the Nature Journals article, about 70% of lung cancers are found in their later stages, they are more difficult to cure. In traditional CT scan diagnosis, the limitations of human vision resulted in missing up to 35% of lung nodules in the initial stage of diagnosis. AI technologies can assist by taking some of the load off for human staff and spot lungs suspected areas that are unseen to the naked eye. Hence, AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes with increasing cancer burden globally.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT, PLEASE VISIT@ https://nforming.com/publications/ai-in-cancer-diagnosis-market/

Upcoming Opportunities in AI in Cancer Diagnosis Market

AI in the development of patient-specific tailored medication and prediction of anticancer treatment sensitivity

Al can play important role in to the development of patient-specific tailored medication (precision medicine) where, AI can predict how tumors progress and evolve, which might aid physicians in generating effective drugs for specific patients and influence future treatment procedures. AI is being used to identify and understand characteristics of target molecules (such as proteins or nucleic acids that are crucial for the progression of cancer), predict new medications that will target those molecules, and assess the efficacy of those therapies.

More, AI has a rapid understanding of how anticancer treatment resistance develops in cancer cells, which can also help in medication development and dosage adjustments.

Thus, this will a big opportunity for players as AI has a significant impact in the development of patient-specific anticancer medication and sensitivity prediction of anticancer treatments.

Major Market Players Covered in The AI in Cancer Diagnosis Market Are:
A few of the major competitors currently working in the global AI in Cancer Diagnosis market are Ibex Medical Analytics Ltd., Qlarity Imaging, Paige AI, Neurologica (Samsung), and Other Companies.

Global AI in Cancer Diagnosis Market Segments

AI in Cancer Diagnosis Market, by Product
• Galen
• QuantX
• Paige Prostate
• Auto Lung Nodule Detection (ALND)
• DeepDx Prostate
• GI Genius
• Others

AI in Cancer Diagnosis Market, by Application
• Nodule Detection
• Tumor Monitoring
• Early Disease Detection
• Work Flow Optimization
• Others

AI in Cancer Diagnosis Market, by End User
• Hospitals & Clinics
• Pathology Laboratory
• Cancer Research Institutes
• Others

Get More Publication Like This @ https://nforming.com/publications-cat/e-reports/

Based on regions, the AI in Cancer Diagnosis Market is classified into North America, Europe, Asia- Pacific, Middle East & Africa, and Latin America
Middle East and Africa (GCC Countries and Egypt)
North America (United States, Mexico, and Canada)
South America (Brazil, Argentina, etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

Contact Us:
nForming Solutions.
India - +91-8080557298
US - +1-973-937-7675
Mail: nfo@nforming.com

Customization of the Report:
nForming Solutions also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to contact our sales team, who will ensure that you get a report per your needs.

This release was published on openPR.